from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2SVvoRu on July 30, 2019 at 01:11AM
While value-based contracting presents an opportunity to address the high costs associated with cancer care, there are still a number of barriers which complicate adoption of those models, the authors of a recent article published on Managed Healthcare Executive write.
Cancer costs, according to the article, are expected to reach roughly $173 billion by 2020.
“Unfortunately, adoption barriers persist, including the lack of technology and infrastructure to track and measure outcomes; growing concerns around patient privacy; misaligned incentive structures; and legislative hurdles, to name a few,” the authors write.
To read the full article on Managed Healthcare Executive, click here.